← Back to Screener
US Stock Screener
HomeScreensNewsWatchlist
...

Venus Concept Inc. (VERO) 10-Year Financial Performance & Capital Metrics

VERO • • Industrial / General
HealthcareMedical DevicesAesthetic & Reconstructive DevicesAesthetic & Hair Restoration Devices
AboutVenus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes aesthetic device platforms, including Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; and Venus Viva, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin. The company also offers Venus Fiore, a device that delivers non-thermal RF with massage and magnetic field pulses to treat various medical conditions; Venus Bliss, a device for non-invasive lipolysis of the abdomen and flanks in individuals with a body mass index of 30 or less; Venus Glow, a dermabrasion device used to improve skin appearance; and NeoGraft, an advanced hair restoration technology with an automated FUE and implantation system. In addition, it provides Venus Velocity and Venus Epileve for hair removal, permanent hair reduction, and treatment of pseudofolliculitis barbae; and ARTAS iX, a robotic system to assist physicians in identifying and extracting hair follicles units from the scalp during hair transplantation, creating recipient sites, and implanting the harvested hair follicles. The company is headquartered in Toronto, Canada.Show more
  • Revenue $65M -15.1%
  • EBITDA -$23M +3.7%
  • Net Income -$47M -26.2%
  • EPS (Diluted) -66.28 -869.0%
  • Gross Margin 68.34%
  • EBITDA Margin -35.93% -13.4%
  • Operating Margin -41.93% -13.1%
  • Net Margin -72.49% -48.6%
  • ROE -1655.95%
  • ROIC -39.8% -32.9%
  • Debt/Equity 15.16
  • Interest Coverage -3.55 +13.5%
Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

  • ✓Share count reduced 87.0% through buybacks
  • ✓Trading at only 0.4x book value

✗Weaknesses

  • ✗High debt to equity ratio of 15.2x
  • ✗Negative free cash flow
  • ✗Weak momentum: RS Rating 9 (bottom 9%)
  • ✗Low quality earnings: Net income not backed by cash flow
  • ✗Sales declining 10.1% over 5 years
  • ✗Trading more than 30% below 52-week high

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-
5Y-10.1%
3Y-15.01%
TTM-12.39%

Profit (Net Income) CAGR

10Y-
5Y-
3Y-
TTM-8.91%

EPS CAGR

10Y-
5Y-
3Y-
TTM-209.73%

ROCE

10Y Avg-71.94%
5Y Avg-37.54%
3Y Avg-41.93%
Latest-54.16%

Peer Comparison

Aesthetic & Hair Restoration Devices
Select Columns
Size & Scale
Valuation
Per Share
Growth
Profitability
Quality & Returns
Safety & Leverage
TTM Growth
Famous Investor Metrics
Dividends
Latest Quarter
Momentum & Returns
Total Return (DRIP)
Technical
Volume & Trading
Shares & Dilution
Sector-Specific
NameMarket CapCurrent PriceP/E RatioRevenue Growth 1YNet MarginROEFCF YieldDebt/Equity
VEROVenus Concept Inc.2.66M1.43-0.02-15.09%-92.76%-17.43%15.16

Profit & Loss

Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024
Sales/Revenue+17.23M15.6M21.3M21.96M110.41M78.01M105.62M99.5M76.35M64.83M
Revenue Growth %--0.09%0.37%0.03%4.03%-0.29%0.35%-0.06%-0.23%-0.15%
Cost of Goods Sold+12.51M10.43M12.15M12.45M33.75M26.62M31.53M33.53M24.19M20.53M
COGS % of Revenue0.73%0.67%0.57%0.57%0.31%0.34%0.3%0.34%0.32%0.32%
Gross Profit+4.72M5.17M9.15M9.51M76.65M51.39M74.09M65.97M52.17M44.31M
Gross Margin %0.27%0.33%0.43%0.43%0.69%0.66%0.7%0.66%0.68%0.68%
Gross Profit Growth %-0.1%0.77%0.04%7.06%-0.33%0.44%-0.11%-0.21%-0.15%
Operating Expenses+25.24M24.1M26.43M35.41M106.93M119.29M88.86M100.85M80.48M71.49M
OpEx % of Revenue1.47%1.54%1.24%1.61%0.97%1.53%0.84%1.01%1.05%1.1%
Selling, General & Admin17.84M16.63M19.29M27.04M98.9M84.08M81.99M89.89M72.28M64.8M
SG&A % of Revenue1.04%1.07%0.91%1.23%0.9%1.08%0.78%0.9%0.95%1%
Research & Development7.4M7.47M7.13M8.37M8.03M7.75M9.65M10.95M8.2M6.69M
R&D % of Revenue0.43%0.48%0.34%0.38%0.07%0.1%0.09%0.11%0.11%0.1%
Other Operating Expenses0000027.45M-2.77M000
Operating Income+-20.52M-18.93M-17.28M-25.91M-30.28M-67.9M-14.77M-34.88M-28.31M-27.18M
Operating Margin %-1.19%-1.21%-0.81%-1.18%-0.27%-0.87%-0.14%-0.35%-0.37%-0.42%
Operating Income Growth %-0.08%0.09%-0.5%-0.17%-1.24%0.78%-1.36%0.19%0.04%
EBITDA+-19.66M-18.28M-16.71M-24.57M-28.24M-63.09M-9.91M-30.41M-24.19M-23.3M
EBITDA Margin %-1.14%-1.17%-0.78%-1.12%-0.26%-0.81%-0.09%-0.31%-0.32%-0.36%
EBITDA Growth %-0.07%0.09%-0.47%-0.15%-1.23%0.84%-2.07%0.2%0.04%
D&A (Non-Cash Add-back)860K654K574K1.34M2.04M4.8M4.85M4.46M4.12M3.89M
EBIT-20.08M-19.36M-15.76M-26.45M-32.59M-73.29M-17.89M-39.74M-30.23M-39.93M
Net Interest Income+-2.89M-2.48M-2.03M-2.22M-7.85M-8.34M-4.96M-4.56M-6.89M-7.66M
Interest Income0000-297K00000
Interest Expense2.89M2.48M2.03M2.22M7.55M8.34M4.96M4.56M6.89M7.66M
Other Income/Expense-2.45M-2.91M-504K-2.77M-10.16M-13.74M-8.08M-9.43M-8.81M-20.4M
Pretax Income+-22.97M-21.85M-17.79M-28.68M-40.44M-81.64M-22.85M-44.31M-37.12M-47.58M
Pretax Margin %-1.33%-1.4%-0.84%-1.31%-0.37%-1.05%-0.22%-0.45%-0.49%-0.73%
Income Tax+0056K47K1.86M1.18M-707K-722K-71K-611K
Effective Tax Rate %1%1%1%1%1%1%1.01%0.99%1%0.99%
Net Income+-22.97M-21.85M-17.84M-28.73M-40.62M-81.71M-23.01M-43.7M-37.25M-47M
Net Margin %-1.33%-1.4%-0.84%-1.31%-0.37%-1.05%-0.22%-0.44%-0.49%-0.72%
Net Income Growth %-0.05%0.18%-0.61%-0.41%-1.01%0.72%-0.9%0.15%-0.26%
Net Income (Continuing)-22.97M-21.85M-17.84M-28.73M-42.3M-82.82M-22.14M-43.58M-37.05M-46.97M
Discontinued Operations0000000000
Minority Interest0004.02M2.5M-471K653K645K570K469K
EPS (Diluted)+-224.21-213.23-152.86-192.87-74.49-33.92-6.34-9.91-6.84-66.28
EPS Growth %-0.05%0.28%-0.26%0.61%0.54%0.81%-0.56%0.31%-8.69%
EPS (Basic)-224.21-213.23-152.86-192.87-74.49-33.92-6.34-9.91-6.84-66.28
Diluted Shares Outstanding102.45K102.45K116.72K148.94K567.8K2.44M3.63M4.4M5.44M709K
Basic Shares Outstanding102.45K102.45K116.72K148.94K567.8K2.44M3.63M4.4M5.44M709K
Dividend Payout Ratio----------

Balance Sheet

Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024
Total Current Assets+25.39M17.94M31.73M29.49M99.7M115.4M110.28M83.71M66.44M48.51M
Cash & Short-Term Investments17.13M11.91M23.55M16.12M15.67M34.3M30.88M11.57M5.4M4.27M
Cash Only17.13M11.91M23.55M16.12M15.67M34.3M30.88M11.57M5.4M4.27M
Short-Term Investments0000000000
Accounts Receivable1.49M2.48M3.86M6.57M58.98M56.35M49.65M39.49M30.57M19.33M
Days Sales Outstanding31.6558.0566.22109.2194.98263.66171.56144.88146.15108.83
Inventory5.63M2.74M2.76M5.52M18.84M17.76M26.21M29.79M28.68M17.56M
Days Inventory Outstanding164.3495.9582.94161.89203.78243.47303.43324.29432.74312.26
Other Current Assets001.56M03.1M2.17M808K1.17M503K495K
Total Non-Current Assets+1.09M1.56M1.24M1.48M91.42M45.12M47.1M41.67M27.21M19.67M
Property, Plant & Equipment988K1.46M1.14M1.3M4.65M3.54M2.67M7.72M5.84M4.22M
Fixed Asset Turnover17.44x10.69x18.71x16.90x23.75x22.04x39.57x12.89x13.08x15.37x
Goodwill0002.6M27.45M00000
Intangible Assets000022.34M18.86M15.39M11.92M8.45M4.97M
Long-Term Investments100K100K100K38.2M35.66M21.15M27.71M20.04M11.32M8.53M
Other Non-Current Assets000-40.92M710K685K1.04M1.04M574K488K
Total Assets+26.48M19.5M32.97M30.97M191.13M160.53M157.37M125.38M93.65M68.18M
Asset Turnover0.65x0.80x0.65x0.71x0.58x0.49x0.67x0.79x0.82x0.95x
Asset Growth %--0.26%0.69%-0.06%5.17%-0.16%-0.02%-0.2%-0.25%-0.27%
Total Current Liabilities+4.96M13.05M14.05M9.38M48.17M32.52M34.72M39.59M31.16M30.29M
Accounts Payable1.03M1.74M2.04M3.81M9.4M6.32M8.42M8.03M9.04M6.48M
Days Payables Outstanding30.0760.8961.4111.85101.6686.6797.4687.46136.39115.3
Short-Term Debt07.45M7.73M49K7.79M0543K9.54M5.75M8.27M
Deferred Revenue (Current)1000K1000K1000K1000K1000K1000K1000K1000K1000K1000K
Other Current Liabilities001.13M1.77M3.14M7.53M18.99M15.5M11.21M6.57M
Current Ratio5.12x1.37x2.26x3.14x2.07x3.55x3.18x2.11x2.13x1.60x
Quick Ratio3.98x1.16x2.06x2.56x1.68x3.00x2.42x1.36x1.21x1.02x
Cash Conversion Cycle165.9293.1187.76159.25297.09420.46377.54381.72442.5305.79
Total Non-Current Liabilities+143.72M149.99M5.73M20.01M66.28M84.25M81.06M77.05M75.94M35.06M
Long-Term Debt19.71M13M5.27M19.42M61.23M79.6M77.33M70M70.79M31.44M
Capital Lease Obligations00000004.22M3.16M2M
Deferred Tax Liabilities0001.89M1.02M811K46K015K0
Other Non-Current Liabilities124.01M136.99M459K594K2.35M2.06M2.33M1.86M1.31M1.26M
Total Liabilities148.68M163.04M19.78M29.39M114.45M116.76M115.78M116.64M107.1M65.35M
Total Debt+19.71M20.45M13M19.47M69.02M79.6M77.87M83.77M79.7M43.03M
Net Debt2.59M8.54M-10.54M3.35M53.35M45.3M46.99M72.2M74.3M38.76M
Debt / Equity--0.99x3.47x0.90x1.82x1.87x9.59x-15.16x
Debt / EBITDA----------
Net Debt / EBITDA----------
Interest Coverage-7.10x-7.62x-8.53x-11.65x-4.01x-8.14x-2.98x-7.65x-4.11x-3.55x
Total Equity+-122.2M-143.54M13.19M5.6M76.68M43.76M41.6M8.74M-13.45M2.84M
Equity Growth %--0.17%1.09%-0.58%12.68%-0.43%-0.05%-0.79%-2.54%1.21%
Book Value per Share-1192.81-1401.10113.0437.63135.0417.9211.461.99-2.474.00
Total Shareholders' Equity-122.2M-143.54M13.19M1.58M74.18M44.23M40.94M8.09M-14.02M2.37M
Common Stock2K2K3K4K24K26K27K29K30K30K
Retained Earnings-124.8M-146.65M-164.49M-193.21M-75.69M-157.39M-180.41M-224.1M-261.9M-308.9M
Treasury Stock0000000000
Accumulated OCI14K14K-79K-50K000000
Minority Interest0004.02M2.5M-471K653K645K570K469K

Cash Flow

Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024
Cash from Operations+-24.12M-16.16M-19.26M-28.7M-39.59M-28.65M-19.77M-26.98M-12.86M-11.07M
Operating CF Margin %-1.4%-1.04%-0.9%-1.31%-0.36%-0.37%-0.19%-0.27%-0.17%-0.17%
Operating CF Growth %-0.33%-0.19%-0.49%-0.38%0.28%0.31%-0.36%0.52%0.14%
Net Income-22.97M-21.85M-17.84M-28.73M-42.3M-82.82M-22.14M-43.58M-37.05M-46.97M
Depreciation & Amortization860K654K574K813K2.04M4.8M4.85M4.46M4.12M3.89M
Stock-Based Compensation429K466K465K667K2.16M2.14M2.07M2.1M1.57M1.04M
Deferred Taxes-578K392K-1.43M1.95M-1.13M-438K-165K-709K-69K-443K
Other Non-Cash Items1.21M737K578K470K12.47M55.38M764K10.33M6.94M19.34M
Working Capital Changes-3.07M3.43M-1.6M-3.87M-12.84M-7.72M-5.15M417K11.64M12.08M
Change in Receivables3.5M-987K-1.38M-4.48M-21.09M93K-869K9.86M14.89M12.49M
Change in Inventory-3.37M2.89M-19K-2.76M6.43M-1.02M-4.26M-5.78M-324K4.46M
Change in Payables-1.93M709K246K1.8M-5.97M-2.98M2.1M-385K1M-2.21M
Cash from Investing+-456K-1.17M1.62M-1.01M6.38M-2.39M-552K-336K-116K-123K
Capital Expenditures-456K-1.17M-229K-1.01M-1.12M-291K-512K-336K-116K-123K
CapEx % of Revenue0.03%0.08%0.01%0.05%0.01%0%0%0%0%0%
Acquisitions----------
Investments----------
Other Investing02K1.85M07.51M00000
Cash from Financing+8.89M12.11M29.37M22.24M42.2M49.67M16.82M8.01M6.8M10.06M
Debt Issued (Net)----------
Equity Issued (Net)----------
Dividends Paid0000000000
Share Repurchases----------
Other Financing111K41K43K392K25.78M-911K817K-101K-275K-126K
Net Change in Cash----------
Free Cash Flow+-24.57M-17.34M-19.48M-29.7M-40.72M-28.94M-20.28M-27.32M-12.97M-11.19M
FCF Margin %-1.43%-1.11%-0.91%-1.35%-0.37%-0.37%-0.19%-0.27%-0.17%-0.17%
FCF Growth %-0.29%-0.12%-0.52%-0.37%0.29%0.3%-0.35%0.53%0.14%
FCF per Share-239.86-169.22-166.94-199.44-71.71-11.85-5.59-6.21-2.38-15.78
FCF Conversion (FCF/Net Income)1.05x0.74x1.08x1.00x0.97x0.35x0.86x0.62x0.35x0.24x
Interest Paid1.45M1.74M1.5M1.76M6.17M1.47M3.29M4.15M4.47M1.61M
Taxes Paid61K56K28K35K1.09M941K116K329K124K128K

Key Ratios

Metric2015201620172018201920202021202220232024
Return on Equity (ROE)---135.23%-305.63%-98.73%-135.68%-53.92%-173.64%--1655.95%
Return on Invested Capital (ROIC)---489.11%-335.02%-32.68%-46.49%-12.47%-30.86%-29.95%-39.8%
Gross Margin27.38%33.13%42.95%43.3%69.43%65.87%70.15%66.3%68.32%68.34%
Net Margin-133.32%-140.04%-83.78%-130.83%-36.79%-104.73%-21.79%-43.92%-48.79%-72.49%
Debt / Equity--0.99x3.47x0.90x1.82x1.87x9.59x-15.16x
Interest Coverage-7.10x-7.62x-8.53x-11.65x-4.01x-8.14x-2.98x-7.65x-4.11x-3.55x
FCF Conversion1.05x0.74x1.08x1.00x0.97x0.35x0.86x0.62x0.35x0.24x
Revenue Growth--9.46%36.52%3.09%402.85%-29.34%35.39%-5.8%-23.26%-15.09%

Revenue by Segment

20172018201920202021202220232024
System--31.73M28.96M43.11M47.91M41.87M38.02M
System Growth----8.74%48.86%11.14%-12.59%-9.20%
Leases--65.17M33.43M45.09M35.27M20.5M13.27M
Leases Growth----48.71%34.90%-21.79%-41.86%-35.31%
Product--6.03M10.86M13.23M13.32M10.56M10.47M
Product Growth---80.07%21.85%0.65%-20.67%-0.89%
Service--7.48M4.77M4.19M3.01M3.41M3.08M
Service Growth----36.18%-12.14%-28.24%13.46%-9.79%

Revenue by Geography

20172018201920202021202220232024
UNITED STATES8.92M13.13M47.72M33.99M53.52M52.1M43.45M38.18M
UNITED STATES Growth-47.24%263.41%-28.78%57.47%-2.65%-16.60%-12.15%
Non-US----52.1M47.4M32.9M26.66M
Non-US Growth------9.03%-30.58%-18.98%
Asia Pacific4.35M4.01M------
Asia Pacific Growth--7.95%------
E M E A5.78M3.5M------
E M E A Growth--39.42%------
Rest Of World2.24M1.31M------
Rest Of World Growth--41.41%------

Frequently Asked Questions

Growth & Financials

Venus Concept Inc. (VERO) reported $58.9M in revenue for fiscal year 2024. This represents a 242% increase from $17.2M in 2015.

Venus Concept Inc. (VERO) saw revenue decline by 15.1% over the past year.

Venus Concept Inc. (VERO) reported a net loss of $54.6M for fiscal year 2024.

Dividend & Returns

Venus Concept Inc. (VERO) has a return on equity (ROE) of -1656.0%. Negative ROE indicates the company is unprofitable.

Venus Concept Inc. (VERO) had negative free cash flow of $20.7M in fiscal year 2024, likely due to heavy capital investments.

VCP Scanner

Find stocks. Verify deeply. Act with conviction.

Patterns find ideas. Fundamentals build conviction.

Data updated daily

Quick Links

  • Home
  • Screens
  • Valuation
  • Compare
  • Total Return
  • News
  • Insights
  • Methodology
  • How It Works
  • Profile

Popular Screens

  • VCP Hot
  • VCP Warm
  • Value Screens
  • Growth Screens
  • Momentum Screens
  • Technical Screens
  • Quality Screens

Community

  • Twitter
  • Get Early Access
© 2026 VCP Scanner. All rights reserved.
Made with ❤️ for investors
Not financial advice. Do your own research.